Alcon AG | ALC - Des Atouts





Des Atouts Changement Date
AstraZeneca USD 115.83B 1.82B 2026-06
Bayer EUR 107.29B 659M 2026-06
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 41.84B 526M 2026-06
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
GRIFOLS EUR 20.09B 12M 2026-06
Lonza CHF 18.97B 164M 2025-12
Merck EUR 52.69B 383M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Philips EUR 26.7B 565M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Smith & Nephew USD 11.01B 321M 2026-06
Sonova Holding CHF 5.92B 468.2M 2025-06
UCB EUR 18.16B 971M 2025-12